Yes, the amount is strikingly the same. But it is not to be found in the Consolidated Statement of Cash Flows, pages 66 and 67 of the latest annual report. The report covers the financial years 19 and 20, and it is not in there. Perhaps, as a part payment, there was an outgoing of $15.596m in FY2019. Zero for FY 2020. I assume, a signing of an agreement, does not translate into cash flows in full immediately. By the same token, if those $15.6m were for payment of Deloraine, then another $20m have to be found to pay for the remainder in the future. Hmmm, that does not improve the outlook in terms of cash flow.
Confused now.
BUB Price at posting:
91.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)